The Bio Report

563 Episoder

1. The Havoc-Wreaking Zombies Lurking in Life Sciences Boardrooms

   Udgivet: 17.3.2016
2. New FDA Chief Faces Challenges

   Udgivet: 10.3.2016
3. Seeking a Best-in-Class Antibody at Bargain Basement Prices

   Udgivet: 3.3.2016
4. Pharma Bro, Price Controls, and the Quest to Balance Innovation with Affordability

   Udgivet: 25.2.2016
5. California’s Stem Cell Agency Plots Its Future

   Udgivet: 18.2.2016
6. ViaCyte Pursues ”Functional Cure” for Type 1 Diabetes

   Udgivet: 11.2.2016
7. Building a Better Pain Pill

   Udgivet: 4.2.2016
8. Project GENIE Hopes to Make Precision Medicine a Reality

   Udgivet: 28.1.2016
9. FDA Wants Industry to Guard Against Cybersecurity Risks of Medical Devices

   Udgivet: 21.1.2016
10. Pharma’s Leadership Vacuum and Its Price to the Industry

    Udgivet: 14.1.2016
11. Permanent R&D Tax Credit a Boost to Life Sciences

    Udgivet: 7.1.2016
12. Biotech in 2015 and the Year Ahead with TheStreet’s Adam Feuerstein

    Udgivet: 31.12.2015
13. Trends Shaping the New Health Economy in 2016

    Udgivet: 24.12.2015
14. Declining R&D Productivity Continues to Plague Big Pharma

    Udgivet: 17.12.2015
15. Searching for Solutions to Rising Specialty Drug Prices

    Udgivet: 10.12.2015
16. Biohackers Seek a Faster, Cheaper Path to Insulin

    Udgivet: 3.12.2015
17. A Scorecard to Improve Drugmakers’ Transparency

    Udgivet: 25.11.2015
18. Forget the Chemistry Set, Mom, I Want a Bioreactor

    Udgivet: 19.11.2015
19. Ensuring Biological Tools Benefit the Environment

    Udgivet: 13.11.2015
20. New SEC Rules Open Crowdfunding to the Masses

    Udgivet: 5.11.2015